Daily Market Movers 01-12-10

FEATURED COMPANY

MUNDUS GROUP INCORPORATED (OTC: MNDP)
"Up 36.36% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MNDP.php

Company Profile: http://www.otcpicks.com/mundus-group.htm

The Mundus Group, Inc. is an advanced aerospace technology consortium providing patented Vertical Take Off and Landing (VTOL) technology for experimental aircraft and Unmanned Air Vehicles (UAV) since 1990 through its fully owned VTOL division, Roadable Aircraft International (RAI). Mundus is at the cutting edge of jet turbine-ducted fan technology and fuses state of the art design engineering and a prototyping facility with computer assisted auto flight technologies, Remote Controlled (RC) and composite technologies industry segments. From US Navy co-developed UAVs for aerial observation and environmental testing to advanced VTOL aerospace technology for civilian and military uses, Mundus Group, Inc. is developing revolutionary products with global potential for change that offers economic protection and growth opportunities for investors.

MNDP News:

January 5 - Mundus Group Subsidiary, AirStar is in Communication With Altitude Inc. of Vancouver, Canada to Supply UAVs and Services for Geological Survey for the Mining Industry

Altitude has developed a 3D analysis software for geological surveys that has been written for Vertical Take Off and Landing (VTOL) Unmanned Air Vehicles (UAVs) that provide an enhanced detail of stratification, faults and rock formations that are unattainable with fixed wing seismic surveys.

Environmental engineers have been challenged with the need for greater predictability regarding sensitive ground waters, faults and construction of roads, bridges and mining interests. The current fixed wing surveys are flown at much higher altitudes and at higher speeds and are much less accurate than the new technology we will be providing.

Mundus Group Inc. (OTC: MNDP) Chairman Keith Michael Field reflects, "The current seismic imaging used by geologists and engineers in search of natural resources including oil and natural gas as well as mining have proven to be most predictable on flat ground surface geography.

"The AirStar UAV is able to slowly hover over a rugged terrain, which allows for a GPS satellite coordinate to lock onto a precision controlled flight path. While hovering and flying with closer proximity to the ground, the UAV can gradually descend into the ravines and steep cliffs, which when combined with Altitude's proprietary 3D analysis software, provide a dramatically enhanced image of what is beneath the cliffs and ravines."

AirStar and Altitude have agreed on their strategic common goals to provide Aerial Imagery & Data collection technologies to geological survey companies in search of natural resources in the Mining of minerals, gemstones, precious metals and natural gas & oil industries.

AirStar and Mundus previously formed Geo Logic as an Aerial delivery system and Green Technology provider with "Small footprint" aerial non-disruptive technologies, to the mining, natural gas and oil industries. Additional benefits that we provide are increased accuracy in the assessment and analysis of resources that safeguard against wasteful miscalculations and environmental destruction.

Critical analysis cannot be made in difficult to reach areas without aerial topography and seismic imagery data from a VTOL vertical takeoff and landing UAV unmanned air vehicle that can hover in one place with the ability to identify precise 3D details with GPS pin point accuracy of location and depth in a stratified cliffs and valleys that cannot be rendered from a moving fixed wing geological pass.

ABOUT AIRSTAR INTL. INC.

AirStar, has been an innovator and world leader in Unmanned Air Vehicles and Remote Controlled Vertical Take off and Landing technology for the past 20 years in the design, engineering, development, production and sales of cutting edge remote controlled (RC) unmanned air vehicles (UAVs) for US military, international government and civilian surveillance services, fire and rescue departments as well as world renowned aerial cinematography for movie and commercial production, aerial photography and laboratory / product data testing.

FEATURED COMPANY

ECOBLU PRODUCTS INCORPORATED (OTCBB: ECOB)

Detailed Quote: http://www.otcpicks.com/quotes/ECOB.php

Company Profile: http://www.otcpicks.com/ecoblu-products.htm

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company's revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies.

ECOB News:

January 12 - EcoBlu Products to be Used in Four Seasons Resort Renovation

EcoBlu Products, Inc. (OTCBB: ECOB) announced that RNM Construction, an authorized EcoBlu Products reseller, has been awarded the framing contract for renovations being done at the Four Seasons Residence Club Aviara, North San Diego. RNM will exclusively be building with EcoBlu products utilizing BLUWOOD™ technology that protect the lumber from mold, rot, decay, termites and fire.

The Four Seasons Residence Club Aviara is located in southern California, just north of San Diego, offering vacation homes in the heart of a unique Pacific coastal community.

"This is another high profile project using EcoBlu products that will help build our brand in the marketplace. The conditions on the Pacific coast are very challenging for wood, but using EcoBlu's BLUWOOD™ technology will protect it from the harsh environment," said Steve Conboy, President and CEO of EcoBlu Products.

FEATURED COMPANY

LUX ENERGY CORPORATION (OTCBB: LUXE)
"Up 9.09% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/LUXE.php

Company Profile: http://www.otcpicks.com/lux-energy-corp/lux-energy-corp.htm

Lux Energy Corp. is an oil and gas production and exploration company focusing on developing oil and gas resources in North America. Further information and news releases are available at www.luxenergycorp.com.

LUXE News:

January 7 - Lux Energy Enters Into Negotiations for a Substantial Position in "E" Well at Its West Central Alberta Project

Lux Energy Corp. (OTCBB: LUXED), an oil and gas production and exploration company, announced that it is negotiating an agreement with the Operator of its West Central Alberta project near Edmonton to acquire a substantial working interest in the "E" well. Lux Energy currently owns positions in A, B, C and D wells in adjoining oil and gas leases.

"E" well is a priority target supported by 3D seismic structure definition. The "E" well is at an offset location to the Company's previously drilled "C" well. The "C" lease is successfully producing with secondary gas credits. This location is a topographic high where fluids naturally migrate, as was witnessed in "C" well. The operator's engineers and technicians prospect that the "E" well should encounter substantial liquids in the target reservoir. The operator points out that the "C" well is free-flowing and not yet stimulated but is successfully producing. This bodes well for the prospects of "E" well. The gathering systems and production facilities are on location and in operation, therefore the well completion can transfer to production status immediately. Revenue and cash flow are a critical feature of this "E" project.

Shane Broesky, President of Lux Energy Corp., comments, "The petroleum engineering and geological surveys of the 'E' lease indicate a superior opportunity. It is the Company's primary target in the Barhead prospects and we are optimistic that this unique opportunity to participate in this proven field will be of great benefit to Lux Energy."

FEATURED COMPANY

QUOTEMEDIA INCORPORATED (OTCBB: QMCI)

Detailed Quote: http://www.otcpicks.com/quotes/QMCI.php

Company Profile: http://www.otcpicks.com/quotemedia/quotemedia.htm

QuoteMedia, Inc. is a leading software developer and provider of real-time streaming financial market information, decision-support, news and research solutions to brokerage, financial services companies, business and media corporations. Among its many leading-edge products lines, the Company offers data feeds, news, dynamic market content solutions, interactive stock research tools, financial applications and real-time wireless applications. QuoteMedia provides data and services for companies such as the NASDAQ, the OTCBB, Dow Jones & Company, Forbes.com, Scotia Capital, Business Wire, Southwest Securities, Regal Securities, FBR Direct, Broadridge Financial Solutions, Inc., AIM Trimark, Zacks Investment Research, ChoiceTrade, QTrade, Schaeffer's Investment Research, Automated Financial Systems, WallStreet*E, and others. For more information, visit www.quotemedia.com.

QMCI News:

November 12 - QuoteMedia Reports Third Quarter Results

QuoteMedia, Inc. (OTCBB: QMCI), a leading provider of market data and financial applications, announced financial results for the three and nine months ended September 30, 2009. These results reflect a 1% increase in third quarter revenue, to $1,910,884 from $1,888,279 in the comparative period in 2008. Revenue for the nine months ended September 30, 2009 increased 7%, to $5,658,444 from $5,300,350 in the comparative period in 2008.

“As forecasted, the global recession moderated QuoteMedia's revenue growth during the first three quarters of 2009,” says Keith Guelpa, President of QuoteMedia, Inc. “The downturn, however, has presented opportunities as the added pressure on financial sector firms to find more efficient and cost effective solutions to their data and technology needs has opened many new doors for QuoteMedia’s offerings. While we have suffered the loss of some smaller clients who have shrunk or ceased operations as a result of the negative market conditions, larger prospective new clients have been approaching us about replacing their current solutions. These larger opportunities generally take extended periods to close and to produce revenue streams, given the scale of the contemplated deployments and the time required to terminate their existing provider contracts. Quotestream Professional, our streaming real-time market data terminal for brokers and financial professionals, continued to garner increasing interest and broader market penetration during the 3rd quarter, with an increasing number of new client firms preparing for their initial rollout. Additionally, the company is in various stages of discussion and negotiation with respect to several large scale enterprise deployments of a wide range of our other product offerings. At a time when most of our competitors are struggling, discontinuing product lines, laying off staff and experiencing significant declines in revenues, we are pleased to see that we are not only weathering the storm, but strengthening and expanding. Given the opportunities we are seeing, and the inroads we’ve made so far this year, we expect strong revenue growth in 2010.

“We experienced a loss for the third quarter of $155,365 compared to a loss of $153,873 in the comparative quarter. The loss for the nine months ended September 30, 2009 was $556,490 compared to a loss of $869,550 in the comparative period. This represents a 36% improvement in operating results for the nine month period. In view of the economic conditions confronting our industry during 2009, we are satisfied with our performance to date, and we believe that we continue to be on target to meet our long term objectives.”

FEATURED COMPANY

BIOMAGNETICS DIAGNOSTICS CORPORATION (OTC: BMGP)

Detailed Quote: http://www.otcpicks.com/quotes/BMGP.php

Company Profile: http://www.otcpicks.com/biomagnetics-diagnostics/biomagnetics-diagnostics.htm

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company's revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies.

BMGP News:

December 28 - Biomagnetics to Become Fully Reporting; CEO Comments on Corporate Growth Plans and Strength of Balance Sheet

Biomagnetics Diagnostics Corp. (OTC: BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, announced it is instituting several actions to become a fully reporting organization, improve transparency to investors and migrate the trading of its common shares to the over-the-counter market. Additionally, corporate management is expressing confidence in achieving growth objectives for 2010.

“With the growth we expect during 2010 it will be important for us to provide full transparency to our investors and other stakeholders," commented Clayton Hardman, CEO of Biomagnetics Diagnostics. “Toward this aim, we have begun implementing plans to complete a full financial audit and to file these audit results with both Pink OTC Markets, Inc. and the Securities and Exchange Commission. We expect these actions to allow us to not only become a fully reporting organization, but also to make us eligible to trade our shares on the OTC market.

These actions include the completion of a full financial audit and the filing of financial disclosure information with Pink OTC Markets Inc. and the U.S. Securities and Exchange Commission. Additionally, the Company will be working with several broker-dealers on Rule 15c2-11 documentation for submission to FINRA in order to receive OTCBB quotation clearance.

“Our balance sheet remains very strong with a meaningful cash balance and minimal debt. We have been able to accomplish this with only very minimal fund-raising activities. This has allowed us to keep the number of total outstanding shares at only approximately 64 million. While we do not anticipate the need to raise growth capital, as our working capital balances are already robust, it is very comforting for us to have the strong backing of our shareholders, many of whom are eager to provide us additional growth capital should it be required. Simply put - our financial position is very strong, which will allow us to aggressively implement our growth strategies. With a total market capitalization of approximately $9 million, we believe our common shares are significantly undervalued.”

“Mr. Hardman continued, “While we realized significant accomplishments in the last four months of 2009, we expect the acceleration of developments in the first half of 2010. During the first quarter, we expect to enter into several certifications in China, India and Africa, which we believe will clearly demonstrate the superiority of our technology and testing cost profile relative to the inferior solutions currently available in today's market. In the first half we expect to expand upon our groundbreaking agreement with Los Alamos National Security, commercialize the integrated optical biosensor technology for the detection of cholera, malaria, tuberculosis and HIV/AIDS, in addition to accelerating development of the technology that will enable multiple detections from a single sample. We are clearly very excited about where Biomagnetics Diagnostics is headed during 2010.”

According to the World Health Organization, some 3.2 billion people, or about half the world's population is at risk of malaria transmission in 107 countries and territories worldwide. While there are between 350 million and 500 million new cases of malaria each year, there are very few reliable and field deployable diagnostic tools available. In the case of malaria, early detection substantially improves treatability and survivability. Field deployable Integrated Optical Biosensor Systems (IBOS), such those Biomagnetics Diagnostics is planning to soon introduce hold the promise to significantly speed the diagnostic testing process and to meaningfully lower costs and improve lives.

STOCKS TO WATCH

ZAREBA SYSTEMS INCORPORATED (NASDAQ: ZRBA)
"Up 93.34% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ZRBA.php

Zareba Systems, Inc., a Minnesota corporation since 1960, is the world’s leading manufacturer of electronic perimeter fence and security systems for animal and access control. The Company’s corporate headquarters is located in Minneapolis, with manufacturing facilities in Ellendale, Minn. Its Zareba Systems Europe subsidiary owns Rutland Electric Fencing Co., the largest manufacturer of electric fencing products in the United Kingdom.

ZRBA News:

January 11 - Zareba Systems, Inc. Announces Merger Agreement with Woodstream Corporation; Zareba Shareholders to Receive $9.00 Cash Per Share

Zareba Systems, Inc. (Nasdaq: ZRBA) announced that it has signed a definitive agreement to merge with a subsidiary of Woodstream Corporation, a Pennsylvania corporation. Woodstream is majority owned by private equity firms Brockway Moran & Partners, Inc. and Code Hennessy & Simmons LLC.

Under the terms of the agreement, a newly-formed subsidiary of Woodstream will merge with and into Zareba, Zareba will become a wholly-owned subsidiary of Woodstream, and Zareba shareholders will receive $9.00 in cash for each outstanding share of Zareba common stock. This price represents a premium of approximately 100% over the closing price of Zareba stock on January 11, 2010. Zareba’s board of directors and a special committee of Zareba’s disinterested directors have unanimously approved the agreement and the merger. The merger is expected to be completed in the first half of 2010 and is subject to Zareba shareholder approval and other customary closing conditions. A special meeting of Zareba shareholders will be announced following preparation and filing of proxy materials with the Securities and Exchange Commission.

“Our board thoroughly explored strategic alternatives for enhancing shareholder value and determined that this transaction with Woodstream represents an excellent value to our shareholders,” stated Zareba President and Chief Executive Officer Dale Nordquist. “Furthermore, our complementary product offerings and market strengths will also result in the substantial utilization of our existing operations and employees going forward.”

“Zareba's and Woodstream's Fi-Shock product offerings are highly complementary and when combined will result in an impressive portfolio of products, brands and intellectual property” stated Woodstream President and Chief Executive Officer Harry E. Whaley. “Zareba's operations will significantly enhance our operating capabilities and allow us to better serve the needs of our customers around the world.”

Greene Holcomb & Fisher LLC acted as financial advisor, and Fredrikson & Byron, P.A. served as legal advisor, to Zareba. William Blair & Company LLC acted as financial advisor, and Faegre & Benson LLP served as legal advisor, to Woodstream.

ABOUT WOODSTREAM CORPORATION

Woodstream Corporation, a Pennsylvania corporation since 1902, is a designer, manufacturer and marketer of a broad range of branded consumer products with facilities in Canada, Colorado, Missouri, Pennsylvania, Tennessee and China. The Company’s product portfolio includes wild bird feeders, organic pest controls, rodent and wild animal control equipment, lawn & garden décor products and animal training and containment products marketed under a variety of brands including Victor®, Fi-Shock®, Safer Brand®, Perky Pet®, Mosquito Magnet® and Havahart®. Woodstream’s products are sold at more than 100,000 retail locations throughout the United States and internationally.

FRESH HARVEST PRODCTS INCORPORATED (OTCBB: FRHV)
"Up 36.67% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/FRHV.php

Fresh Harvest Products, Inc. is a natural and organic food and beverage company. Fresh Harvest offers a line of organic snack products and beverages, which include health bars, coffee bars, and salsa under the Wings of Nature™ name and beverages under the TeAloe™ name. In addition, Fresh Harvest provides a grocery product line, which includes several varieties of whole bean and ground coffees, and beverages. We sell our products through specialty and natural food distributors to stores, specialty supermarkets and retailers. Fresh Harvest Products, Inc. is headquartered in New York City.

FRHV News:

January 12 - Fresh Harvest's Products Will Be Carried in Walgreens

Fresh Harvest Products, Inc. (OTCBB: FRHV) announced that the company will be selling its Wings of Nature™ Organic Snack Bars to Walgreens starting in its Orlando region. The products will be available in approximately 200 retail locations and will consist of our top organic snack bar flavors. Placement in the stores will be up front at the checkout and should begin later this month.

Fresh Harvest's CEO Michael J. Friedman stated, "This is a great entry into a national chain, and we will actively be working towards expanding into additional regions. We will now work aggressively towards a successful marketing program targeted to customers of Walgreens throughout the Orlando area. The Orlando area represents a very good customer base for the Company. We believe that the state of Florida is a great place to further increase our expansion and growth of our products and distribution."

ABOUT WALGREENS

Walgreens (www.walgreens.com) is the nation's largest drugstore chain with fiscal 2009 sales of $63 billion. The company operates 7,149 drugstores in all 50 states, the District of Columbia and Puerto Rico. Walgreens provides the most convenient access to consumer goods and services and cost-effective pharmacy, health and wellness services in America through its retail drugstores, Walgreens Health Services division and Walgreens Health and Wellness division. Walgreens Health Services assists pharmacy patients and prescription drug and medical plans through Walgreens Health Initiatives Inc. (a pharmacy benefit manager), Walgreens Mail Service Inc., Walgreens Home Care Inc., Walgreens Specialty Pharmacy LLC and SeniorMed LLC (a pharmacy provider to long-term care facilities). Walgreens Health and Wellness Division includes Take Care Health Systems, the largest and most comprehensive manager of worksite health and wellness centers and in-store convenient care clinics, with more than 700 locations throughout the country.

GENTA INCORPORATED (OTCBB: GETA)
"Up 22.22% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/GETA.php

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company’s research platform: DNA/RNA-based Medicines and Small Molecules. Genasense® (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. The leading drug in Genta’s Small Molecule program is Ganite® (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, which has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. Ganite and Genasense are available on a “named-patient” basis in countries outside the United States.

GETA News:

January 12 - Two New Studies Show Gallium-Containing Compounds Significantly Increase Bone Strength in Standard Models of Osteoporosis

Genta Incorporated (OTCBB: GETA) announced publication of two scientific studies that test the active ingredient in Genta’s program to develop orally available gallium-containing compounds and the Company’s marketed product, Ganite® (gallium nitrate for injection). In these studies, a compound containing the active ingredient was tested in a widely accepted animal model of established osteoporosis. The new data show that extended treatment with the active ingredient significantly increased bone volume and calcium content in animals with induced osteoporosis. In addition, the increase in new bone formation was associated with a significant restoration of bone strength back to normal levels.

Previous studies have shown that extended in vivo treatment with low-dose gallium in normal animals was associated with increased bone content of calcium and phosphorous, a decrease in bone resorption, a possible increase in new bone formation, and no deleterious effects upon bone biomechanical strength. Moreover, preliminary clinical studies in patients with bone involvement from myeloma, breast cancer, and other malignant diseases had shown biochemical evidence of decreased resorption and increased bone density. Decreased bone resorption has also been reported in patients with advanced Paget’s disease, a metabolic bone disorder. However, no studies have previously examined whether these effects could be replicated in osteoporosis, the most prevalent metabolic bone disease.

In the new studies, a model that simulates post-menopausal osteoporosis was used to induce bone loss. The active ingredient was administered for 8 weeks in an inorganic form (similar to Ganite®) and also in an organic form (comparable to the Company’s orally available gallium-containing compounds). Micro-CT scanning showed that treatment significantly increased both trabecular and cortical bone volume by 49% and 32%, respectively. These findings were confirmed by histomorphometry. Additional analysis revealed a significant increase in bone calcium content. Since some drugs used for clinical treatment of osteoporosis (including certain bisphosphonates) are associated with a decrease in bone strength, biomechanical studies were performed in order to assess the quality of the newly formed bone. These studies showed that bone from treated animals had been restored to levels that were both fully comparable to normal controls and significantly superior to untreated osteoporotic controls.

Together, these new data confirm that – in osteoporotic bone – gallium treatment is associated with significant increases in bone mineral content, bone volume, and new bone formation that is biomechanically normal – findings that had been previously described only in bone that was normal at baseline. These data strongly suggest that gallium-containing compounds exert anti-resorptive and anabolic effects on bone metabolism, and that such compounds may be broadly useful for a wide spectrum of bone-losing disorders.

MEDICAL CARE TECHNOLOGIES INCORPORATED (OTCBB: MDCE)
"Up 5.05% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MDCE.php

Medical Care Technologies Inc. is traded under the symbol "MDCE" on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended and will constitute a healthcare delivery and wellness site; dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business, technology and information systems to assist the Asian health industry — physicians, pharmacists, medical institutions, consumers — access medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals.

MDCE News:

January 12 - Medical Care Technologies Inc. Completes International Secure Practice Management Suite for Testing in China

Medical Care Technologies Inc. (OTCBB: MDCE) announces the completion of a secure practice management system for medical clinics in China. The deployment of our MedSuite technology will allow the first test site in Hebei Province to institute a secure interoperable network through which patient charts can be shared between facilities. The system is designed so physicians and other medical care providers can securely and easily exchange patient information.

Along with the workflow efficiencies, and cost reduction expected through the use of MedSuite, medical clinics throughout China will gain additional efficiencies through the utilization of patient focused TelehealthSuite, which will allow patients to benefit from the use of health information systems as well. With TelehealthSuite, patients are able to obtain appointments, register and complete their medical history, view labs and x-rays, consult directly with their medical provider, acquire prescription refills and monitor their personal health records, all through our secure TelehealthSuite software.

Patricia Traczykowski, President of MDCE, stated, "MedSuite will help facilitate the secure and controlled sharing of data and patient information throughout the health systems where we deploy. Our goal is to create an integrated healthcare system throughout clinics in Asia using our software, whereby physicians will have access to the relevant critical information that will enable them to better administer patient treatment. Additionally, patients can be proactive in their health care by contributing timely health data and dialoguing with health practitioners between appointments."

January 11 - Medical Care Technologies Inc. Signs Asset Acquisition Agreement

Medical Care Technologies Inc. (OTCBB: MDCE) announced that it has reached a definitive agreement to acquire various technologies from Great Union Corporation, ("GUC") a private Hong Kong corporation.

The Boards of Directors of both companies have unanimously approved the transaction.

Pursuant to the Agreement, and in consideration of 57,300,000 of its common stock, MDCE will acquire GUC's technologies associated with the development and maintenance of secure information systems which increase access to medical resources services, education and wellness, pharmaceutical and nutraceutical products. The transaction is subject to customary closing conditions.

Management believes that the acquisition is a significant step in MDCE's strategy to enter into China's lucrative health care market. With life expectancy of the Chinese population gradually increasing, and as China's population becomes wealthier, patients are demanding better lifestyles and better quality care.

According to the US World Nutraceutical Ingredients Industry, it states that the "World demand for nutrients and minerals is projected to reach $12.6 billion in 2013, it too has predicted that China and India will emerge as the most rapidly expanding nutraceutical ingredient markets as strong economic growth allows them to upgrade and diversify food, beverage and drug production capabilities." It also goes on to state, that "China will remain the largest worldwide producer based on its extensive fine chemicals industry and aggressive pursuit of exports."

In China alone nutraceutical sales are estimated to be worth approximately $6 billion in annual sales, according to the China Health Care Association, which is an association attached to China's Ministry of Health. Although the industry is young compared with the U.S., and about one-fourth its size, the potential for sizeable growth is significant due to China's rapid economic growth and increasing consumer demand for natural products that promote health and overall wellness.

Patricia Traczykowski, President of MDCE, goes on to state, "I am very excited for our shareholders and for the Company with our most recent acquisition. It is an acquisition which will allow us to target an expanding healthcare segment and will allow us to venture into a country like China which is full of opportunities. Our values will be simple, using technology to provide better health. We plan to offer affordable, standardized and secure software information systems to electronically connect Healthcare Providers, Academic Institutions, Pharmaceutical and Nutraceutical Companies, Alternative Health Industries, and Individual Consumers with healthcare information, products and services in China. Initially, we aim to generate e-management revenues and nutraceutical and pharmaceutical product distribution revenues. Concurrent with and in addition to our main revenue streams, we hope to add to our bottom line through content licensing fees, email marketing revenues and e-commerce."

Management intends to immediately begin the process of integrating its technology, services and products into Asia once the registration of the share transfer is completed and it has obtained transfer of the assets, all as contemplated by the Asset Acquisition Agreement.

BERGAMO ACQUISITION CORPORATION (OTC: BGMO)
"Up 2.94% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/BGMO.php

Bergamo Acquisition Corp., through its wholly owned subsidiary, Bergamo E&A Corp., focuses on the development of clean energy infrastructure projects in Pakistan. The company involves in the construction of mission-critical infrastructure, including clean energy electric plants, solar renewable energy projects, and LED high efficiency lighting projects. It also provides construction management and facility maintenance services. In addition, Bergamo Acquisition Corp. engages in wholesale business that focuses on women’s urban fashion apparel and accessories comprising recognized brands. The company is headquartered in Henderson, Nevada.

BGMO News:

January 12 - Bergamo Acquisition Corp. Announces Historic Funding in the Amount of $100 Million USD

Bergamo Acquisition Corp. (OTC: BGMO) announced the Company has closed on a $100 Million USD financing yesterday, January 11, 2010. The financing is with ESoft Informatics Private Ltd, in conjunction with Newby & Associates, Shannon K. Newby, President. The contract, as executed, requires the deposit of $25 Million USD into Bergamo Acquisition Corp's CitiBank account in Henderson, Nevada. An additional $75 Million USD must be deposited into the same account no later than 22 banking days from yesterday's closing.

These funds will help facilitate the domestic funding as previously announced in connection with the acquisitions of GreenSafe Demanufacturing, Inc., Suntrough Energy, Inc., the Japanese mobile software company acquisition announced yesterday, and the financial services industry subsidiary the Company intends to announce later this week.

Bergamo President Hillard Herzog commented on this historic funding, "Yesterday we closed the biggest funding in the history of Bergamo Acquisition Corp. This now locks in the domestic funding of $250 Million USD. This means that we can immediately this week move on our acquisitions for the benefit of our shareholders. By the end of this week we will also have funded the required application fees for our Pakistan Energy Projects that is connected with our receiving the $1 Billion USD Sovereign Bank Guarantee from the Government of Pakistan which insures the payment of all energy from the Pakistani Energy Projects."

The purpose of this news release is to clarify the point that all of the announced acquisitions that the company has signed tentatively will be finalized sometime this week. These include Suntrough Energy, Inc., GreenSafe Demanufacturing, Inc., the Japanese mobile software company and the financial services subsidiary.

The Company has been asked repeatedly to indicate that funding has taken place. The Company can now assure shareholders that $25 Million USD will be deposited into the Company's bank account as agreed, and the remaining $75 Million USD balance due will be received and deposited no later than 22 banking days from the closing date of the agreement yesterday. The Company can further assure our shareholders that this is just the beginning of what the Company has committed to do. The Company will be updating shareholders on a regular basis with the progress in all of these areas.

FIDELIS ENERGY INCORPORATED (OTC: FDEI)
"Up 17.65% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/FDEI.php

Fidelis Energy Inc. ("FDEI") is an energy company focused on developing, constructing and operating solar energy projects exclusively or in partnership with other energy companies. Fidelis is also in the development stage of designing solar photovoltaic (PV) cell technology products and plans to manufacture and distribute these products in the future. Fidelis owns a unique patent pending solar cell technology based on photovoltaic cells with integral light-transmitting wave guides in a ceramic sleeve. The advantage of this technology is the efficiency of less exposed surface area being required to generate electricity. The light-transmitting particles act as wave guides and allow the sun-exposed conversion area of the solar cell to be shifted readily from horizontal to vertical to capture more sunlight. The ceramic sleeve eliminates the need for expensive vacuum chambers, thereby allowing less expensive materials to be used in solar cell production. We are developing, with plans to eventually manufacture and market, innovative solar cells and solar power products for a wide range of applications based on our technology that increases light-trapping while enabling a variety of materials to be used. Our technology employs multiple stacked solar cells in a ceramic sleeve that uses nano-particles and crystal wave guides to carry light from the opening down to the last junction in the solar cell. Competitors' processes that use vacuum chambers (instead of a ceramic sleeve) generally don't allow for material substitution because of contamination issues. We believe our technology will also allow manufacturers to quickly and economically shift to new materials if a shortage of any one type of material occurs. In general, our technology will offer a flexible, cost-effective solution for increased light-trapping and will provide increased efficiency.

FDEI News:

January 11 - Fidelis Energy Announces $25 Million Solar Energy Facility in India

Fidelis Energy Inc. (OTC: FDEI) ("Fidelis" or the "Company") announced a $25 million agreement with Esar Solar Power Pvt. Ltd. (ESP), a Jaipur-based company, to develop and construct the first of several solar energy projects located in the Thar Desert near Jaisalmer, India. The region is destined to become the world's biggest solar power house as it basks in an average of 330 days of sunshine per year and receives up to 6.2KW per hour of solar energy per square meter everyday, which is the highest in the world.

Within the scope of this project, which firmly establishes Fidelis in the international arena of solar power developers, the Company will design and construct a multi-megawatt solar power system that will supply and support the community's energy grid system to meet a consistently increasing demand.

"India represents the first of many untapped solar power markets that Fidelis plans to enter in 2010 and 2011," said James Poole, CEO of Fidelis Energy Inc. "While international projects pose special challenges for solar energy producers, such as identifying proper high voltage lines and the ownership of the property prior to system installation," added Poole, "our unique ability and expertise to overcome such challenges makes Fidelis Energy the natural choice for clients with challenging power needs."

Recognizing the role that solar power will play in the global search for cleaner and more abundant energy sources, Fidelis Energy has built the infrastructure necessary to support this type of international expansion to facilitate the development of large-scale projects at an accelerated pace to support global power needs.

Fidelis Energy will provide the technology, engineering and construction services needed to create the PV Project. ESP has signed a 10-year power purchase and sale agreement with the state's government-owned power distribution company.

"We recognize that the continued use of fossil fuels negatively impacts both the economy and the environment," said Esar Solar Power Chairman Jagdish Singh. "As such, ESP is determined to meet a portion of India's energy requirements by developing several large solar photovoltaic projects (PV Projects), which will generate electricity from sunlight. Fidelis has shown that it has the ability and innovative construction techniques to execute this contract, and we look forward to this project beginning in May of 2010," added Singh. "It is the goal of both parties to complete the construction of the five megawatt (5MW) PV Project and start its operations before October of 2010."

In July 2009, India unveiled a $19 billion plan to produce 20 GW of solar power by 2020. Under the plan, solar-powered equipment and applications would be mandatory in all government buildings including hospitals and hotels. On November 18, 2009, it was reported that India was ready to launch its Solar Mission under the National Action Plan on Climate Change, with plans to generate 1,000 MW of power by 2013.